nach oben

Erschienen in:

01.06.2023 | Clinical study

Third mRNA COVID-19 vaccine dose well tolerated in infants and young children

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

A third mRNA COVID-19 vaccine dose is generally well tolerated in infants and young children, according to findings of a US study published in Morbidity and Mortality Weekly Report . …

Hause AM, et al. Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months-5 Years - United States, June 17, 2022-May 7, 2023. Morbidity and Mortality Weekly Report 72: 621-626, No. 23, et al. Jun 2023. Available from: URL: http://doi.org/10.15585/mmwr.mm7223a2

Titel: Third mRNA COVID-19 vaccine dose well tolerated in infants and young children
Publikationsdatum: 01.06.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-41269-9

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Third mRNA COVID-19 vaccine dose well tolerated in infants and young children

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Amantadine/droxidopa

Tozinameran

Bisoprolol

Azd-1222/elasomeran

Elasomeran

Antineoplastics